NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 5.33% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.28% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 5.08% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 4.98% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.93% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 4.83% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.75% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.67% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.63% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.62% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.59% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 4.56% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.2% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.15% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 3.96% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 3.73% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.4% |
| ARVN | Arvinas Inc | Healthcare | Biotechnology | 2.51% |
| AMPH | Amphastar P | Healthcare | Drug Manufacturers - Specialty & Generic | 2.18% |
| SAVA | Cassava Sciences Inc | Healthcare | Biotechnology | 2.13% |
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).